Vanta Bioscience

51.23
+1.75
(3.54%)
Market Cap (₹ Cr.)
₹31
52 Week High
101.64
Book Value
₹28
52 Week Low
37.00
PE Ratio
PB Ratio
2.05
PE for Sector
34.31
PB for Sector
4.27
ROE
-55.18 %
ROCE
-4.92 %
Dividend Yield
0.00 %
EPS
₹0.00
Industry
Miscellaneous
Sector
Miscellaneous
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
41.16 %
Net Income Growth
17.60 %
Cash Flow Change
525.40 %
ROE
-20.23 %
ROCE
28.42 %
EBITDA Margin (Avg.)
-158.91 %

Financial Results

Quarterly Financials
Dec 2021
Mar 2022
Dec 2022
Mar 2023
Revenue
0
4
2
2
Expenses
0
3
1
3
EBITDA
0
2
0
-1
Operating Profit %
0 %
36 %
19 %
-64 %
Depreciation
0
1
1
0
Interest
0
1
1
1
Profit Before Tax
0
-0
-1
-1
Tax
0
-0
0
0
Net Profit
0
-0
-2
-1
EPS in ₹
0.00
-0.27
-2.39
0.00

Balance Sheet

Balance Sheet
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
14
29
38
42
46
50
52
53
Fixed Assets
13
17
18
21
29
36
37
38
Current Assets
1
9
14
17
14
11
11
12
Capital Work in Progress
0
2
4
0
0
0
0
0
Investments
0
5
2
0
0
0
0
0
Other Assets
1
5
14
21
17
14
14
15
Total Liabilities
8
13
16
18
22
26
32
33
Current Liabilities
0
2
3
7
11
10
10
14
Non Current Liabilities
8
10
13
11
11
16
22
19
Total Equity
6
17
22
23
24
24
20
20
Reserve & Surplus
3
11
16
17
18
18
13
13
Share Capital
4
6
6
6
6
6
6
6

Cash Flow

Cash Flow
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
-0
0
-0
-0
0
0
0
Investing Activities
-13
-8
-5
-2
-10
-8
-3
-2
Operating Activities
-0
-7
-0
3
11
7
1
5
Financing Activities
14
14
5
-2
-1
1
2
-3

Share Holding

% Holding
Mar 2021
Sept 2021
Mar 2022
Sept 2022
Mar 2023
Sept 2023
Mar 2024
Promoter
69.11 %
69.00 %
69.00 %
69.36 %
69.36 %
69.36 %
69.36 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.89 %
31.00 %
31.00 %
30.64 %
30.64 %
30.64 %
30.64 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
94.11 99,782.32 - 9,206.96 26.66 -829 -2,104.57 48.44
365.45 17,003.76 39.89 2,538.97 -7.00 495 -24.37 60.71
78.96 10,965.54 9.55 6,191.69 49.62 424 377.88 47.19
585.15 9,507.87 26.89 2,298.69 19.14 347 7.72 62.28
417.85 6,024.20 36.56 12,304.09 8.13 190 -28.25 51.43
180.20 5,970.21 - 18,320.16 -13.24 -796 -121.72 59.31
127.82 5,742.56 16.32 5,071.42 1.77 346 8.19 37.67
1,036.50 5,438.91 17.28 1,211.62 7.67 300 5.79 41.30
3,045.15 5,155.43 49.93 9,367.71 18.37 113 -24.81 42.53
702.10 4,999.79 - 874.80 54.62 -18 133.57 44.19

Corporate Action

Technical Indicators

RSI(14)
Neutral
52.85
ATR(14)
Less Volatile
2.74
STOCH(9,6)
Neutral
76.07
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
0.67
ADX(14)
Weak Trend
18.04
UO(9)
Bearish
72.09
ROC(12)
Uptrend And Accelerating
4.55
WillR(14)
Neutral
-23.40